123 related articles for article (PubMed ID: 9471931)
1. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women.
Best PJ; Berger PB; Miller VM; Lerman A
Ann Intern Med; 1998 Feb; 128(4):285-8. PubMed ID: 9471931
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women.
Saitta A; Altavilla D; Cucinotta D; Morabito N; Frisina N; Corrado F; D'Anna R; Lasco A; Squadrito G; Gaudio A; Cancellieri F; Arcoraci V; Squadrito F
Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1512-9. PubMed ID: 11557681
[TBL] [Abstract][Full Text] [Related]
3. The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal women.
Squadrito F; Altavilla D; Morabito N; Crisafulli A; D'Anna R; Corrado F; Ruggeri P; Campo GM; Calapai G; Caputi AP; Squadrito G
Atherosclerosis; 2002 Aug; 163(2):339-47. PubMed ID: 12052481
[TBL] [Abstract][Full Text] [Related]
4. Effects of estrogen replacement therapy on plasma levels of nitric oxide in postmenopausal women.
Cicinelli E; Ignarro LJ; Matteo MG; Galantino P; Schonauer LM; Falco N
Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):334-9. PubMed ID: 9988796
[TBL] [Abstract][Full Text] [Related]
5. [The effect of estrogen replacement therapy on plasma nitric oxide levels in postmenopausal women].
Ye Y; Dai S; Zhang S
Zhonghua Fu Chan Ke Za Zhi; 1998 Jun; 33(6):340-1. PubMed ID: 10806670
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 and nitric oxide levels are related to cardiovascular risk factors but are not modified by estradiol replacement in healthy postmenopausal women. A cross-sectional and a randomized cross-over study.
Cagnacci A; Tarquini R; Perfetto F; Arangino S; Zanni AL; Cagnacci P; Facchinetti F; Volpe A
Maturitas; 2003 Feb; 44(2):117-24. PubMed ID: 12590007
[TBL] [Abstract][Full Text] [Related]
7. The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane.
Ylikorkala O; Cacciatore B; Paakkari I; Tikkanen MJ; Viinikka L; Toivonen J
Fertil Steril; 1998 May; 69(5):883-8. PubMed ID: 9591497
[TBL] [Abstract][Full Text] [Related]
8. [Changes of nitric oxide and endothelin plasma levels and effects of hormone replacement therapy in postmenopausal women].
Lai A; Zhang J; Ding L
Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):222-4. PubMed ID: 11776165
[TBL] [Abstract][Full Text] [Related]
9. Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors.
Wilcox JG; Hatch IE; Gentzschein E; Stanczyk FZ; Lobo RA
Fertil Steril; 1997 Feb; 67(2):273-7. PubMed ID: 9022602
[TBL] [Abstract][Full Text] [Related]
10. [Effects of sex hormones on serum levels of nitric oxide and plasma angiotensin II in postmenopausal women].
Zheng X; He FF; Nie M; Sun ML; Ge QS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):635-8. PubMed ID: 12905695
[TBL] [Abstract][Full Text] [Related]
11. Effects of estrogen-progestin and raloxifene therapy on nitric oxide, prostacyclin and endothelin-1 synthesis.
Christodoulakos G; Panoulis C; Kouskouni E; Chondros C; Dendrinos S; Creatsas G
Gynecol Endocrinol; 2002 Feb; 16(1):9-17. PubMed ID: 11915588
[TBL] [Abstract][Full Text] [Related]
12. 17beta-estradiol decreases endothelin-1 levels in the coronary circulation of postmenopausal women with coronary artery disease.
Webb CM; Ghatei MA; McNeill JG; Collins P
Circulation; 2000 Oct; 102(14):1617-22. PubMed ID: 11015337
[TBL] [Abstract][Full Text] [Related]
13. Vascular effects of simvastatin are similar to hormone replacement therapy in postmenopausal women.
Ociepka A; Milewicz T; Kialka M; Krzyczkowska-Sendrakowska M
Przegl Lek; 2016; 73(5):280-6. PubMed ID: 29629740
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.
Imthurn B; Rosselli M; Jaeger AW; Keller PJ; Dubey RK
J Clin Endocrinol Metab; 1997 Feb; 82(2):388-94. PubMed ID: 9024224
[TBL] [Abstract][Full Text] [Related]
15. A novel concept to preserve the beneficial effects of hormone replacement therapy in bilaterally female ovariectomized rats: role of lovastatin therapy.
El-Swefy SE; Asker ME; Ali SI; Mohammed HE
Pharmacol Res; 2002 Mar; 45(3):167-73. PubMed ID: 11884211
[TBL] [Abstract][Full Text] [Related]
16. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
Kurtay G; Ozmen B; Erguder I
Maturitas; 2006 Jan; 53(1):32-8. PubMed ID: 16325022
[TBL] [Abstract][Full Text] [Related]
17. Effect of estrogen on nitric oxide and endothelin-1.
Brody JI
Ann Intern Med; 1998 Jul; 129(2):160. PubMed ID: 9669978
[No Abstract] [Full Text] [Related]
18. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.
Balci H; Altunyurt S; Acar B; Fadiloglu M; Kirkali G; Onvural B
Maturitas; 2005 Apr; 50(4):289-93. PubMed ID: 15780528
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy in healthy postmenopausal women. Effects on intraplatelet cyclic guanosine monophosphate, plasma endothelin-1 and neopterin.
Anwaar I; Rendell M; Gottsäter A; Lindgärde F; Hulthén UL; Mattiasson I
J Intern Med; 2000 Apr; 247(4):463-70. PubMed ID: 10792560
[TBL] [Abstract][Full Text] [Related]
20. The effect of the menstrual cycle and of ethinylestradiol on nitric oxide, endothelin-1 and homocysteine plasma levels.
Merki-Feld GS; Imthurn B; Keller PJ
Horm Metab Res; 2000 Jul; 32(7):288-93. PubMed ID: 10965936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
